 Emily DeBoer
Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deglutition Disorders | 7 | 2025 | 143 | 2.480 |
Why?
| | Bronchiectasis | 5 | 2024 | 111 | 2.390 |
Why?
| | Down Syndrome | 6 | 2025 | 496 | 2.240 |
Why?
| | Esophageal Atresia | 4 | 2022 | 26 | 2.110 |
Why?
| | Tracheoesophageal Fistula | 4 | 2022 | 33 | 2.090 |
Why?
| | Lung Diseases, Interstitial | 7 | 2024 | 638 | 1.920 |
Why?
| | Bronchoscopy | 8 | 2021 | 223 | 1.640 |
Why?
| | Cystic Fibrosis | 7 | 2022 | 1114 | 1.390 |
Why?
| | Oscillometry | 2 | 2025 | 42 | 1.090 |
Why?
| | Child | 35 | 2025 | 21935 | 1.080 |
Why?
| | Tomography, X-Ray Computed | 9 | 2024 | 2691 | 1.050 |
Why?
| | Computer Simulation | 3 | 2021 | 978 | 1.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2019 | 652 | 1.020 |
Why?
| | Proteomics | 5 | 2023 | 1111 | 0.960 |
Why?
| | Airway Resistance | 2 | 2025 | 41 | 0.950 |
Why?
| | Lung | 12 | 2025 | 4060 | 0.920 |
Why?
| | Idiopathic Pulmonary Fibrosis | 4 | 2024 | 657 | 0.850 |
Why?
| | Delphi Technique | 2 | 2024 | 280 | 0.810 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2023 | 128 | 0.800 |
Why?
| | Airway Obstruction | 2 | 2021 | 162 | 0.790 |
Why?
| | Resilience, Psychological | 1 | 2024 | 128 | 0.770 |
Why?
| | Lung Diseases | 2 | 2020 | 767 | 0.760 |
Why?
| | Respiration Disorders | 2 | 2020 | 77 | 0.730 |
Why?
| | Hydrodynamics | 1 | 2021 | 45 | 0.710 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2021 | 45 | 0.700 |
Why?
| | Protein C | 1 | 2021 | 59 | 0.690 |
Why?
| | Burnout, Professional | 2 | 2024 | 442 | 0.690 |
Why?
| | Deglutition | 5 | 2025 | 72 | 0.670 |
Why?
| | Heart Diseases | 1 | 2023 | 346 | 0.640 |
Why?
| | Autoimmune Diseases | 1 | 2024 | 460 | 0.640 |
Why?
| | Intellectual Disability | 1 | 2021 | 165 | 0.630 |
Why?
| | Gastrointestinal Diseases | 2 | 2018 | 209 | 0.620 |
Why?
| | Tomography | 2 | 2021 | 40 | 0.620 |
Why?
| | Models, Anatomic | 2 | 2020 | 93 | 0.600 |
Why?
| | Child, Preschool | 16 | 2025 | 11074 | 0.600 |
Why?
| | Air | 1 | 2018 | 37 | 0.580 |
Why?
| | Health Status | 1 | 2023 | 792 | 0.580 |
Why?
| | Vascular Diseases | 1 | 2020 | 243 | 0.570 |
Why?
| | Aptamers, Nucleotide | 1 | 2019 | 83 | 0.560 |
Why?
| | Humans | 50 | 2025 | 137585 | 0.560 |
Why?
| | Trachea | 4 | 2020 | 237 | 0.550 |
Why?
| | Respiration | 1 | 2018 | 199 | 0.550 |
Why?
| | Sleep Wake Disorders | 1 | 2020 | 286 | 0.540 |
Why?
| | Infant | 12 | 2021 | 9465 | 0.500 |
Why?
| | Pneumonia | 1 | 2021 | 639 | 0.470 |
Why?
| | Tracheomalacia | 3 | 2020 | 17 | 0.470 |
Why?
| | Bronchi | 1 | 2015 | 260 | 0.430 |
Why?
| | Gastroesophageal Reflux | 2 | 2015 | 234 | 0.430 |
Why?
| | Automation | 1 | 2014 | 95 | 0.420 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 752 | 0.420 |
Why?
| | Models, Biological | 1 | 2021 | 1783 | 0.420 |
Why?
| | Respiratory Tract Diseases | 3 | 2019 | 184 | 0.400 |
Why?
| | Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2012 | 5 | 0.380 |
Why?
| | Retrospective Studies | 14 | 2022 | 15657 | 0.380 |
Why?
| | Hypertension, Pulmonary | 1 | 2023 | 1910 | 0.370 |
Why?
| | Esophagoscopy | 3 | 2019 | 209 | 0.370 |
Why?
| | Models, Statistical | 1 | 2015 | 669 | 0.360 |
Why?
| | Twins, Monozygotic | 1 | 2012 | 203 | 0.350 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3566 | 0.350 |
Why?
| | Family Health | 1 | 2012 | 196 | 0.350 |
Why?
| | Diseases in Twins | 1 | 2012 | 169 | 0.350 |
Why?
| | Male | 22 | 2025 | 67762 | 0.340 |
Why?
| | Patient Readmission | 1 | 2016 | 697 | 0.340 |
Why?
| | Electric Impedance | 3 | 2021 | 107 | 0.330 |
Why?
| | Female | 22 | 2025 | 73304 | 0.320 |
Why?
| | Adolescent | 14 | 2025 | 21513 | 0.320 |
Why?
| | Referral and Consultation | 1 | 2015 | 786 | 0.320 |
Why?
| | Consensus | 2 | 2024 | 683 | 0.310 |
Why?
| | Neuroendocrine Cells | 2 | 2019 | 32 | 0.300 |
Why?
| | Eosinophilic Esophagitis | 3 | 2019 | 325 | 0.300 |
Why?
| | Thoracoscopy | 2 | 2019 | 56 | 0.290 |
Why?
| | Respiratory Function Tests | 2 | 2025 | 600 | 0.290 |
Why?
| | Electronic Health Records | 1 | 2016 | 1069 | 0.290 |
Why?
| | Internship and Residency | 1 | 2018 | 1147 | 0.280 |
Why?
| | Asthma | 1 | 2021 | 2295 | 0.280 |
Why?
| | Patient Care Team | 2 | 2024 | 631 | 0.250 |
Why?
| | Case-Control Studies | 3 | 2019 | 3556 | 0.250 |
Why?
| | Prospective Studies | 4 | 2025 | 7604 | 0.240 |
Why?
| | Heart Defects, Congenital | 2 | 2025 | 842 | 0.230 |
Why?
| | Albuterol | 1 | 2025 | 110 | 0.230 |
Why?
| | Young Adult | 6 | 2023 | 13209 | 0.220 |
Why?
| | Postoperative Complications | 1 | 2016 | 2654 | 0.220 |
Why?
| | Respiratory Rate | 1 | 2023 | 20 | 0.210 |
Why?
| | Gastroenterology | 2 | 2023 | 180 | 0.210 |
Why?
| | Disease Progression | 4 | 2024 | 2757 | 0.200 |
Why?
| | Vital Capacity | 3 | 2024 | 311 | 0.200 |
Why?
| | Hyperplasia | 2 | 2019 | 175 | 0.190 |
Why?
| | Respiratory System Agents | 1 | 2022 | 22 | 0.190 |
Why?
| | Aspergillosis, Allergic Bronchopulmonary | 1 | 2021 | 11 | 0.190 |
Why?
| | Pediatricians | 1 | 2023 | 129 | 0.190 |
Why?
| | Insufflation | 1 | 2021 | 12 | 0.180 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2024 | 228 | 0.180 |
Why?
| | Laryngoscopy | 2 | 2020 | 109 | 0.180 |
Why?
| | Spinal Muscular Atrophies of Childhood | 1 | 2021 | 17 | 0.180 |
Why?
| | Medicine | 1 | 2023 | 121 | 0.180 |
Why?
| | Prognosis | 2 | 2024 | 4030 | 0.180 |
Why?
| | Pulmonary Ventilation | 1 | 2021 | 79 | 0.170 |
Why?
| | Job Satisfaction | 1 | 2023 | 218 | 0.170 |
Why?
| | Indoles | 1 | 2024 | 412 | 0.170 |
Why?
| | Surface-Active Agents | 1 | 2021 | 91 | 0.170 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2025 | 293 | 0.170 |
Why?
| | Spirometry | 1 | 2021 | 281 | 0.170 |
Why?
| | Aminophenols | 1 | 2022 | 156 | 0.160 |
Why?
| | Laryngoscopes | 1 | 2020 | 38 | 0.160 |
Why?
| | Adult | 6 | 2024 | 37929 | 0.160 |
Why?
| | Bronchodilator Agents | 1 | 2021 | 252 | 0.160 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5472 | 0.160 |
Why?
| | Heart | 1 | 2023 | 655 | 0.160 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2019 | 16 | 0.150 |
Why?
| | Ultrasonography | 1 | 2023 | 759 | 0.150 |
Why?
| | Digestive System Diseases | 1 | 2019 | 26 | 0.150 |
Why?
| | Esophageal pH Monitoring | 1 | 2018 | 23 | 0.150 |
Why?
| | Comorbidity | 2 | 2020 | 1622 | 0.150 |
Why?
| | Equipment Design | 1 | 2020 | 522 | 0.150 |
Why?
| | Formative Feedback | 1 | 2018 | 28 | 0.150 |
Why?
| | Esophageal Mucosa | 1 | 2018 | 22 | 0.140 |
Why?
| | Sleep | 1 | 2024 | 755 | 0.140 |
Why?
| | Bronchiolitis Obliterans | 1 | 2018 | 69 | 0.140 |
Why?
| | Virtual Reality | 1 | 2019 | 61 | 0.140 |
Why?
| | Caregivers | 1 | 2025 | 877 | 0.140 |
Why?
| | Diet | 1 | 2025 | 1278 | 0.130 |
Why?
| | Biomarkers | 2 | 2019 | 4149 | 0.130 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 232 | 0.130 |
Why?
| | Gastrostomy | 1 | 2018 | 117 | 0.130 |
Why?
| | Phenotype | 1 | 2025 | 3196 | 0.130 |
Why?
| | Hospitals, Pediatric | 2 | 2019 | 508 | 0.130 |
Why?
| | Pediatrics | 1 | 2024 | 1101 | 0.120 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 261 | 0.120 |
Why?
| | Patient-Centered Care | 1 | 2021 | 530 | 0.120 |
Why?
| | Respiration, Artificial | 1 | 2020 | 645 | 0.120 |
Why?
| | Program Development | 1 | 2018 | 364 | 0.120 |
Why?
| | Anesthesia | 1 | 2018 | 189 | 0.120 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1483 | 0.120 |
Why?
| | Principal Component Analysis | 1 | 2015 | 195 | 0.120 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2015 | 34 | 0.120 |
Why?
| | Patient Satisfaction | 2 | 2019 | 660 | 0.120 |
Why?
| | Demography | 1 | 2015 | 291 | 0.110 |
Why?
| | Long-Term Care | 1 | 2015 | 107 | 0.110 |
Why?
| | Larynx | 1 | 2014 | 60 | 0.110 |
Why?
| | ROC Curve | 1 | 2015 | 554 | 0.110 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 580 | 0.110 |
Why?
| | Congenital Abnormalities | 1 | 2014 | 92 | 0.110 |
Why?
| | Diagnostic Imaging | 1 | 2016 | 332 | 0.110 |
Why?
| | United States | 3 | 2023 | 14841 | 0.100 |
Why?
| | Ambulatory Care | 1 | 2018 | 546 | 0.100 |
Why?
| | Inflammation | 2 | 2022 | 2837 | 0.100 |
Why?
| | Mutation | 2 | 2022 | 3958 | 0.100 |
Why?
| | Infant, Newborn | 4 | 2020 | 6079 | 0.100 |
Why?
| | Quality of Life | 1 | 2025 | 2892 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3284 | 0.100 |
Why?
| | Pandemics | 1 | 2020 | 1639 | 0.090 |
Why?
| | Genes, Recessive | 1 | 2012 | 78 | 0.090 |
Why?
| | Fatal Outcome | 1 | 2012 | 303 | 0.090 |
Why?
| | Fibrosis | 2 | 2024 | 552 | 0.080 |
Why?
| | Clinical Competence | 1 | 2018 | 1118 | 0.080 |
Why?
| | Logistic Models | 1 | 2015 | 2074 | 0.080 |
Why?
| | Endoscopy, Digestive System | 2 | 2024 | 136 | 0.080 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 623 | 0.080 |
Why?
| | Colorado | 2 | 2019 | 4565 | 0.080 |
Why?
| | Esophagus | 2 | 2024 | 255 | 0.080 |
Why?
| | Survival Rate | 1 | 2014 | 1972 | 0.080 |
Why?
| | Follow-Up Studies | 2 | 2019 | 5131 | 0.080 |
Why?
| | Body Mass Index | 1 | 2017 | 2389 | 0.070 |
Why?
| | Algorithms | 1 | 2015 | 1704 | 0.070 |
Why?
| | Quality Improvement | 1 | 2016 | 1178 | 0.070 |
Why?
| | Time Factors | 2 | 2019 | 6828 | 0.070 |
Why?
| | Feasibility Studies | 2 | 2021 | 956 | 0.060 |
Why?
| | Sex Factors | 1 | 2012 | 2071 | 0.060 |
Why?
| | Biopsy | 2 | 2019 | 1129 | 0.050 |
Why?
| | Calreticulin | 1 | 2022 | 28 | 0.050 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2022 | 32 | 0.050 |
Why?
| | HMGB Proteins | 1 | 2022 | 18 | 0.050 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2022 | 74 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2024 | 405 | 0.050 |
Why?
| | Aspergillus fumigatus | 1 | 2021 | 26 | 0.050 |
Why?
| | Risk Factors | 1 | 2016 | 10388 | 0.050 |
Why?
| | Lung Volume Measurements | 1 | 2021 | 46 | 0.050 |
Why?
| | Patient Compliance | 1 | 2025 | 581 | 0.040 |
Why?
| | Leptin | 1 | 2022 | 236 | 0.040 |
Why?
| | Needles | 1 | 2020 | 59 | 0.040 |
Why?
| | Positive-Pressure Respiration | 1 | 2020 | 80 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 319 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2020 | 199 | 0.040 |
Why?
| | Noninvasive Ventilation | 1 | 2020 | 51 | 0.040 |
Why?
| | Printing, Three-Dimensional | 1 | 2020 | 95 | 0.040 |
Why?
| | Pressure | 1 | 2020 | 225 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2025 | 654 | 0.040 |
Why?
| | Speech-Language Pathology | 1 | 2019 | 24 | 0.040 |
Why?
| | Pseudomonas aeruginosa | 1 | 2021 | 352 | 0.040 |
Why?
| | Social Support | 1 | 2023 | 618 | 0.040 |
Why?
| | Fluoroscopy | 1 | 2019 | 154 | 0.040 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2022 | 329 | 0.040 |
Why?
| | Pulmonary Medicine | 1 | 2019 | 85 | 0.040 |
Why?
| | Bronchioles | 1 | 2018 | 23 | 0.040 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 140 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1993 | 0.040 |
Why?
| | Emotions | 1 | 2023 | 548 | 0.040 |
Why?
| | Interdisciplinary Research | 1 | 2018 | 27 | 0.040 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 110 | 0.030 |
Why?
| | Rare Diseases | 1 | 2018 | 104 | 0.030 |
Why?
| | Anesthetics | 1 | 2018 | 81 | 0.030 |
Why?
| | Otolaryngology | 1 | 2019 | 96 | 0.030 |
Why?
| | Lipids | 1 | 2022 | 672 | 0.030 |
Why?
| | Proteome | 1 | 2022 | 472 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2025 | 2828 | 0.030 |
Why?
| | Endoscopy | 1 | 2019 | 318 | 0.030 |
Why?
| | Perioperative Care | 1 | 2018 | 178 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2018 | 216 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1060 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1710 | 0.030 |
Why?
| | Health Services Research | 1 | 2018 | 404 | 0.030 |
Why?
| | Mouth | 1 | 2015 | 87 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1050 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 628 | 0.030 |
Why?
| | Program Evaluation | 1 | 2019 | 898 | 0.030 |
Why?
| | Respiratory Aspiration | 1 | 2014 | 31 | 0.030 |
Why?
| | Animals | 1 | 2016 | 36940 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2019 | 642 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 131 | 0.030 |
Why?
| | Research Design | 1 | 2019 | 1139 | 0.030 |
Why?
| | Middle Aged | 1 | 2014 | 33479 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2023 | 5778 | 0.020 |
Why?
| | Respiratory Tract Infections | 1 | 2014 | 390 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 10811 | 0.010 |
Why?
|
|
DeBoer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|